How to Check Speciality Medicines IPO Allotment Status

Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals, including high-cost oral and injectable medications used to treat complex chronic conditions, across both domestic and international markets.

The company's portfolio includes a wide range of speciality pharmaceutical finished formulations products, available in various dosage forms such as tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.

Speciality Medicines IPO is a book build issue of ₹29.14 crore, entirely comprising a fresh issue of 0.24 crore shares aggregating to ₹29.14 crore. The IPO opened on March 20, 2026, and closed on March 24, 2026. The allotment is expected on Wednesday, March 25, 2026. The share price band was set at ₹117 to ₹124 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Speciality Medicines IPO Allotment Status on Registrar Site

• Visit the BSE IPO Allotment Status Page Skyline Financial Services Pvt. Ltd.
• Select "Speciality Medicines" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Speciality Medicines IPO Allotment Status on BSE/NSE

• Navigate to the BSE SME IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Speciality Medicines" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Speciality Medicines IPO Subscription Status

Speciality Medicines IPO subscribed 2.27 times overall. Here is the category-wise breakdown as of 5:14:39 PM on March 24, 2026:

• QIB Category (Ex Anchor): 96.24 times
• Non-Institutional Investors (NII): 1.88 times
• Individual Investors: 0.85 times

Speciality Medicines IPO Share Price and Investment Details

The minimum investment required was ₹2,48,000 for 2 lots (2,000 shares) for individual investors. The issue includes a reservation of up to 1,50,000 shares for the market maker, Aikyam Capital Private Limited. Given the overall subscription of 2.27 times with exceptional institutional interest at 96.24 times, moderate NII participation at 1.88 times, and weak individual investor subscription at 0.85 times, the share price listing expectations remain positive.

Utilisation of IPO Proceeds

The proceeds will be utilised for setting up of a Research and Development (R&D) Centre at Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat (₹12.68 crore), product registration in international markets and product development for sale in international markets (₹2.99 crore), funding for marketing and promotional activities (₹1.66 crore), meeting working capital requirements (₹8.00 crore), and general corporate purposes.

Business Overview

Speciality Medicines Limited is engaged in the business of marketing and distribution of finished formulations of specialty pharma products globally. The company marked growth in its top and bottom lines for the reported periods. A surge in profits from FY25 onwards raises eyebrows and concern over sustainability. Though the issue appears lucratively priced based on its recent financial data, it is due to higher profits shown for recent years.

The company demonstrated financial performance with total income of ₹58.54 crore for FY2025 and a net worth of ₹36.47 crore as of October 31, 2025. The company benefits from a diversified global presence, a diversified product portfolio, long-standing client relationships, experienced promoters and management team, and quality assurance. However, investors should note the post-issue P/E ratio of 10.49 and Price to Book Value of 2.19.